1. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor. (January 2018) Authors: Yan, Junya; Wu, Xiaowen; Yu, Jiayi; Yu, Huan; Xu, Tianxiao; Brown, Kevin M.; Bai, Xue; Dai, Jie; Ma, Meng; Tang, Huan; Si, Lu; Chi, Zhihong; Sheng, Xinan; Cui, Chuanliang; Kong, Yan; Guo, Jun Journal: European journal of cancer Issue: Volume 89(2018) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial. (September 2017) Authors: Yan, Xieqiao; Sheng, Xinan; Tang, Bixia; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Mao, Li Li; Lian, Bin; Li, Siming; Zhou, Li; Wang, Xuan; Bai, Xue; Kong, Yan; Dai, Jie; Guo, Jun Journal: Lancet oncology Issue: Volume 18(2017)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (1st September 2022) Authors: Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law... Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (20th May 2022) Authors: Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law... Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics. Issue 6 (December 2018) Authors: Yan, Junya; Wu, Xiaowen; Yu, Jiayi; Ma, Meng; Yu, Huan; Xu, Tianxiao; Tang, Huan; Xu, Longwen; Dai, Jie; Si, Lu; Chi, Zhihong; Sheng, Xinan; Cui, Chuanliang; Guo, Jun; Kong, Yan Journal: Melanoma research Issue: Volume 28:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck. (2nd January 2022) Authors: Guo, Wei; Yin, Gaofei; Cui, Chuanliang; Kong, Yan; Huang, Zhigang; Chen, Xiaohong Journal: Acta oto-laryngologica Issue: Volume 142:Number 1(2022) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. (September 2016) Authors: Sheng, Xinan; Kong, Yan; Li, Yiqian; Zhang, Qiannan; Si, Lu; Cui, Chuanliang; Chi, Zhihong; Tang, Bixia; Mao, Lili; Lian, Bin; Wang, Xuan; Yan, Xieqiao; Li, Siming; Dai, Jie; Guo, Jun Journal: European journal of cancer Issue: Volume 65(2016) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis. Issue 6 (11th May 2018) Authors: Xu, Tianxiao; Ma, Meng; Chi, Zhihong; Si, Lu; Sheng, Xinan; Cui, Chuanliang; Dai, Jie; Yu, Sifan; Yan, Junya; Yu, Huan; Wu, Xiaowen; Tang, Huan; Yu, Jiayi; Kong, Yan; Guo, Jun Journal: Cancer science Issue: Volume 109:Issue 6(2018) Page Start: 1787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗